Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
9-ethyladenine | [no description available] | medium | 1 | 0 | | |
purine | [no description available] | medium | 3 | 0 | purine | |
n(6),n(6)-dimethyladenine | [no description available] | medium | 2 | 0 | tertiary amine | |
1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
sq 22536 | [no description available] | medium | 1 | 0 | nucleoside analogue; oxolanes | EC 4.6.1.1 (adenylate cyclase) inhibitor |
adenosine diphosphate | [no description available] | medium | 1 | 0 | adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | fundamental metabolite; human metabolite |
adenosine monophosphate | [no description available] | medium | 1 | 0 | adenosine 5'-phosphate; purine ribonucleoside 5'-monophosphate | adenosine A1 receptor agonist; cofactor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.11 (fructose-bisphosphatase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
2-aminopurine | [no description available] | medium | 2 | 0 | 2-aminopurines; nucleobase analogue | antimetabolite |
alpha-aminopyridine | [no description available] | medium | 1 | 0 | | |
9-benzyladenine | [no description available] | medium | 1 | 0 | | |
adenosine | [no description available] | medium | 2 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
benzylaminopurine | [no description available] | medium | 1 | 0 | 6-aminopurines | cytokinin; plant metabolite |
4-aminopyrimidine | [no description available] | medium | 1 | 0 | aminopyrimidine | |
9-methyladenine | [no description available] | medium | 1 | 0 | methyladenine | metabolite |
6-methoxypurine | [no description available] | medium | 1 | 0 | | |
7-methyladenine | [no description available] | medium | 1 | 0 | methyladenine | metabolite |
1-aminoisoquinoline | [no description available] | medium | 1 | 0 | | |
4-aminoquinazoline | [no description available] | medium | 1 | 0 | | |
3-deazaadenine | [no description available] | medium | 1 | 0 | | |
6-methylpurine | [no description available] | medium | 1 | 0 | purines | EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor |
1-methyladenine | [no description available] | medium | 1 | 0 | | |
3-methyladenine | [no description available] | medium | 1 | 0 | | |
adenine | [no description available] | medium | 102 | 0 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
adenine | [no description available] | medium | 102 | 1 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
5,6-dimethylbenzimidazole | [no description available] | medium | 1 | 0 | dimethylbenzimidazole | Escherichia coli metabolite; human metabolite |
5-methylbenzimidazole | [no description available] | medium | 1 | 0 | imidazoles | |
2,6-diaminopurine | [no description available] | medium | 1 | 0 | 2,6-diaminopurines; primary amino compound | antineoplastic agent |
o-(6)-methylguanine | [no description available] | medium | 1 | 0 | methylguanine | mutagen |
1-methylxanthine | [no description available] | medium | 1 | 0 | 1-methylxanthine | mouse metabolite |
thioguanine anhydrous | [no description available] | medium | 1 | 0 | 2-aminopurines | anticoronaviral agent; antimetabolite; antineoplastic agent |
2-amino-6-chloropurine | [no description available] | medium | 1 | 0 | 2-aminopurines; organochlorine compound | |
allopurinol | [no description available] | medium | 9 | 0 | nucleobase analogue; organic heterobicyclic compound | antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger |
miltefosine | [no description available] | medium | 1 | 0 | phosphocholines; phospholipid | anti-inflammatory agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antiprotozoal drug; apoptosis inducer; immunomodulator; protein kinase inhibitor |
tubercidin | [no description available] | medium | 1 | 0 | antibiotic antifungal agent; N-glycosylpyrrolopyrimidine; ribonucleoside | antimetabolite; antineoplastic agent; bacterial metabolite |
benzonidazole | [no description available] | medium | 1 | 0 | C-nitro compound; imidazoles; monocarboxylic acid amide | antiprotozoal drug |
allopurinol riboside | [no description available] | medium | 4 | 0 | nucleoside analogue | metabolite |
ly2584702 | [no description available] | medium | 2 | 1 | | |
pyrimidine | [no description available] | medium | 4 | 0 | diazine; pyrimidines | Daphnia magna metabolite |
tetrahexylammonium | [no description available] | medium | 1 | 0 | | |
2-aminopyrimidine | [no description available] | medium | 1 | 0 | aminopyrimidine | |
substance p | [no description available] | medium | 2 | 0 | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent |
neurotensin | [no description available] | medium | 2 | 0 | peptide hormone | human metabolite; mitogen; neurotransmitter; vulnerary |
corticosterone | [no description available] | medium | 8 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
cycloheximide | [no description available] | medium | 2 | 0 | antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol | anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor |
8-bromo cyclic adenosine monophosphate | [no description available] | medium | 1 | 0 | 3',5'-cyclic purine nucleotide; adenyl ribonucleotide; organobromine compound | antidepressant; protein kinase agonist |
aldosterone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde | human metabolite; mouse metabolite |
tisopurine | [no description available] | medium | 3 | 0 | pyrazolopyrimidine | |
formycins | [no description available] | medium | 3 | 0 | | |
formycin b | [no description available] | medium | 3 | 0 | formycin | |
thiopurinol ribonucleoside | [no description available] | medium | 3 | 0 | | |
inosine | [no description available] | medium | 1 | 0 | inosines; purines D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
phosphatidylcholines | [no description available] | medium | 1 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
ethinyl estradiol | [no description available] | medium | 4 | 0 | 17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound | xenoestrogen |
tyloxapol | [no description available] | medium | 3 | 0 | | |
leucine | [no description available] | medium | 1 | 0 | amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
mevalonic acid | [no description available] | medium | 1 | 0 | 3,5-dihydroxy-3-methylpentanoic acid | |
pregnenolone | [no description available] | medium | 1 | 0 | 20-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; C21-steroid | human metabolite; mouse metabolite |
aminoglutethimide | [no description available] | medium | 5 | 0 | dicarboximide; piperidones; substituted aniline | adrenergic agent; anticonvulsant; antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor |
cholesteryl oleate | [no description available] | medium | 1 | 0 | CE(18:1); cholesteryl octadec-9-enoate | mouse metabolite |
d-alpha tocopherol | [no description available] | medium | 1 | 0 | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite |
metallothionein | [no description available] | medium | 2 | 0 | | |
dimethyl sulfoxide | [no description available] | medium | 1 | 0 | sulfoxide; volatile organic compound | alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger |
simvastatin | [no description available] | medium | 1 | 0 | delta-lactone; fatty acid ester; hexahydronaphthalenes; statin (semi-synthetic) | EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; ferroptosis inducer; geroprotector; prodrug |
lovastatin | [no description available] | medium | 2 | 0 | delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug |
azaguanine | [no description available] | medium | 1 | 0 | nucleobase analogue; triazolopyrimidines | antimetabolite; antineoplastic agent; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor |
riboflavin | [no description available] | medium | 1 | 0 | flavin; vitamin B2 | anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite |
oleic acid | [no description available] | medium | 1 | 0 | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent |
uridine triphosphate | [no description available] | medium | 1 | 0 | pyrimidine ribonucleoside 5'-triphosphate; uridine 5'-phosphate | Escherichia coli metabolite; mouse metabolite |
glycogen | [no description available] | medium | 1 | 0 | | |
cholesteryl linoleyl ether | [no description available] | medium | 1 | 0 | | |
tyramine | [no description available] | medium | 1 | 0 | monoamine molecular messenger; primary amino compound; tyramines | EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter |
dilactitol tyramine | [no description available] | medium | 1 | 0 | | |
iodine | [no description available] | medium | 1 | 0 | diatomic iodine | nutrient |
phenyl acetate | [no description available] | medium | 1 | 0 | benzenes; phenyl acetates | |
1-anilino-8-naphthalenesulfonate | [no description available] | medium | 1 | 0 | aminonaphthalene; naphthalenesulfonic acid | fluorescent probe |
formycin | [no description available] | medium | 1 | 0 | formycin | antineoplastic agent |
adenosine kinase | [no description available] | medium | 1 | 0 | | |
naloxone | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
oligonucleotides | [no description available] | medium | 5 | 0 | | |
phosphoramidite | [no description available] | medium | 3 | 0 | | |
uracil | [no description available] | medium | 2 | 0 | pyrimidine nucleobase; pyrimidone | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite |
glycosides | [no description available] | medium | 1 | 0 | | |
silver | [no description available] | medium | 1 | 0 | copper group element atom; elemental silver | Escherichia coli metabolite |
7-deazapurine | [no description available] | medium | 1 | 0 | | |
azides | [no description available] | medium | 1 | 0 | pseudohalide anion | mitochondrial respiratory-chain inhibitor |
azauracil | [no description available] | medium | 1 | 0 | 1,2,4-triazines; nucleobase analogue | antimetabolite |
pyrroles | [no description available] | medium | 1 | 0 | pyrrole; secondary amine | |
guanine | [no description available] | medium | 1 | 0 | 2-aminopurines; oxopurine; purine nucleobase | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
7-deazaguanine | [no description available] | medium | 1 | 0 | organic molecular entity | |